Tilray Inc (NASDAQ:TLRY – Get Free Report)’s share price traded up 1.4% on Monday . The company traded as high as $1.77 and last traded at $1.77. 2,569,867 shares traded hands during mid-day trading, a decline of 90% from the average session volume of 25,098,781 shares. The stock had previously closed at $1.74.
Tilray Stock Up 3.2 %
The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.42 and a current ratio of 2.27. The company has a market capitalization of $1.51 billion, a PE ratio of -4.01 and a beta of 2.13. The firm’s 50-day simple moving average is $1.82 and its 200 day simple moving average is $1.87.
Tilray (NASDAQ:TLRY – Get Free Report) last released its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The firm had revenue of $229.90 million during the quarter, compared to analysts’ expectations of $226.20 million. Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The business’s revenue for the quarter was up 24.8% on a year-over-year basis. During the same period in the previous year, the business earned ($0.15) earnings per share. As a group, equities research analysts forecast that Tilray Inc will post -0.16 earnings per share for the current year.
Hedge Funds Weigh In On Tilray
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Further Reading
- Five stocks we like better than Tilray
- How to Plot Fibonacci Price Inflection Levels
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.